# Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial

> **NCT07478003** · PHASE3 · RECRUITING · sponsor: **Thomas Engstrom** · enrollment: 5204 (estimated)

## Conditions studied

- STEMI - ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Methylprednisolone 250 mg
- **DRUG:** NaCl (0,9%)

## Key facts

- **NCT ID:** NCT07478003
- **Lead sponsor:** Thomas Engstrom
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2031-04-20
- **Final completion:** 2036-04-01
- **Target enrollment:** 5204 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07478003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07478003, "Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07478003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*